|
Market Closed -
OTC Markets
20:17:51 04/06/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1250 USD | -13.79% |
|
+1,258.70% | -72.07% |
Company Valuation: ProPhase Labs, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 106.5 | 111 | 156.8 | 81.56 | 18.08 | 2.067 |
| Change | - | 4.23% | 41.18% | -47.97% | -77.84% | -88.57% |
| Enterprise Value (EV) 1 | 112.8 | 108.7 | 146.3 | 98.21 | 41.97 | 10.59 |
| Change | - | -3.65% | 34.61% | -32.86% | -57.26% | -74.76% |
| P/E | -50.1x | 18.1x | 9.41x | -4.61x | -0.29x | -0.26x |
| PBR | 10.1x | 1.89x | 2.45x | 1.65x | 3.08x | 1.14x |
| PEG | - | -0x | 0x | 0x | -0x | 0x |
| Capitalization / Revenue | 7.34x | 1.4x | 1.28x | 1.84x | 2.67x | 0.48x |
| EV / Revenue | 7.77x | 1.37x | 1.19x | 2.21x | 6.2x | 2.44x |
| EV / EBITDA | -31.9x | 8.34x | 5.17x | -6.4x | -1.29x | -0.8x |
| EV / EBIT | -28.3x | 11.1x | 6.2x | -4.54x | -1.09x | -0.59x |
| EV / FCF | 30.2x | -5.49x | 6.97x | -23.1x | 8.37x | 0.25x |
| FCF Yield | 3.31% | -18.2% | 14.3% | -4.33% | 12% | 406% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.833 | 3.954 | 10.24 | -9.8 | -26.08 | -1.737 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 14.51 | 79.04 | 122.6 | 44.38 | 6.77 | 4.345 |
| EBITDA 1 | -3.536 | 13.04 | 28.31 | -15.34 | -32.44 | -13.22 |
| EBIT 1 | -3.985 | 9.801 | 23.6 | -21.61 | -38.63 | -18.05 |
| Net income 1 | -2.125 | 6.273 | 18.46 | -16.78 | -53.36 | -14.74 |
| Net Debt 1 | 6.267 | -2.362 | -10.48 | 16.64 | 23.9 | 8.528 |
| Reference price 2 | 91.800000 | 71.700000 | 96.300000 | 45.200000 | 7.571000 | 0.447500 |
| Nbr of stocks (in thousands) | 1,160 | 1,549 | 1,628 | 1,805 | 2,387 | 4,618 |
| Announcement Date | 31/03/21 | 31/03/22 | 29/03/23 | 29/03/24 | 01/04/25 | 01/06/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 140K | |
| 13.15x | 0.4x | 8.38x | 2.95% | 115B | |
| 15.63x | 1.89x | 9.41x | 0.66% | 98.85B | |
| -288.65x | 20.15x | -340.61x | -.--% | 59.72B | |
| 14.48x | 1.57x | 9.5x | 2.44% | 30.06B | |
| 26.78x | 2.33x | 13.22x | 0.8% | 29.34B | |
| 24.39x | 2.71x | 13.74x | 1.31% | 27.71B | |
| 7.48x | 1.45x | 6.41x | -.--% | 21.75B | |
| 30.62x | 5.47x | 22.33x | 2.28% | 20.66B | |
| 30.38x | 2.86x | 12.88x | 1.46% | 17.09B | |
| Average | -13.97x | 4.31x | -27.19x | 1.32% | 42.06B | |
| Weighted average by Cap. | -26.07x | 4.33x | -39.39x | 1.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PRPH Stock
- Valuation ProPhase Labs, Inc.
Select your edition
All financial news and data tailored to specific country editions
